← Back to Screener
LeonaBio, Inc. Common Stock (LONA)
Price$8.86
Favorite Metrics
Price vs S&P 500 (26W)124.41%
Price vs S&P 500 (4W)-20.18%
Market Capitalization$83.23M
All Metrics
Book Value / Share (Quarterly)$2.98
Cash Flow / Share (Quarterly)$-4.90
Price vs S&P 500 (YTD)12.90%
EPS (TTM)$-21.31
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-21.31
EPS (Annual)$-24.70
ROI (Annual)-380.03%
Cash / Share (Quarterly)$9.46
ROA (Last FY)-114.60%
EBITD / Share (TTM)$-24.47
ROE (5Y Avg)-148.87%
Cash Flow / Share (Annual)$-4.90
P/B Ratio2.99x
P/B Ratio (Quarterly)0.99x
Net Income / Employee (Annual)$-4
Net Interest Coverage (TTM)-18.57x
ROA (TTM)-209.91%
EPS Incl Extra (Annual)$-24.70
Current Ratio (Annual)1.88x
Quick Ratio (Quarterly)1.86x
3-Month Avg Trading Volume0.76M
52-Week Price Return286.90%
Revenue / Employee (TTM)$0
52-Week High$14.21
EPS Excl Extra (Annual)$-24.70
26-Week Price Return133.16%
Quick Ratio (Annual)1.86x
13-Week Price Return34.65%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.88x
Enterprise Value$13.951
Revenue / Employee (Annual)$0
Cash / Share (Annual)$9.46
3-Month Return Std Dev125.09%
Net Income / Employee (TTM)$-4
ROE (Last FY)-380.03%
EPS Basic Excl Extra (Annual)$-24.70
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-21.31
Receivables Turnover (Annual)0.00x
ROI (TTM)-340.97%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)251.80%
Year-to-Date Return17.04%
5-Day Price Return-8.66%
EPS Normalized (Annual)$-24.70
ROA (5Y Avg)-81.30%
Month-to-Date Return-13.81%
EBITD / Share (Annual)$-24.47
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-148.87%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-21.31
P/B Ratio (Annual)0.99x
Book Value / Share (Annual)$2.98
Price vs S&P 500 (13W)31.79%
Beta2.04x
Revenue / Share (TTM)$0.00
ROE (TTM)-340.97%
52-Week Low$2.20
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.29
2.29
4.00
4.00
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
LONALeonaBio, Inc. Common Stock | — | — | — | — | $8.86 |
AMGNAmgen Inc | 5.21x | 9.95% | 73.30% | 2.93% | $355.30 |
GILDGilead Sciences Inc | 5.80x | 2.40% | 78.83% | 133.64% | $137.64 |
ARGXargenx SE American Depositary Shares | 12.46x | 89.56% | 150.91% | — | $849.04 |
BNTXBioNTech SE American Depositary Share | 8.99x | -11.81% | 84.21% | — | $102.92 |
BIIBBiogen Inc. Common Stock | 2.63x | 2.22% | 75.69% | -18.77% | $177.35 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $53.72 |
NBIXNeurocrine Biosciences Inc | 4.68x | 21.45% | 98.18% | 2.31% | $133.25 |
EXELExelixis Inc | 5.02x | 6.85% | 96.39% | 31.10% | $44.89 |
TECHBio-Techne Corp. | 7.62x | 1.64% | 66.60% | -20.58% | $59.23 |
HALOHalozyme Therapeutics, Inc. | 5.88x | 37.55% | 83.62% | 22.89% | $69.29 |
About
LeonaBio Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for serious diseases with significant unmet medical needs. The company focuses on treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS), two conditions with limited existing treatment options. LeonaBio's pipeline targets patient populations facing critical therapeutic gaps and represents potential first-in-class or best-in-class opportunities.